Millipore Sigma Vibrant Logo

MABF2185-100UG Anti-Dengue Virus 2 NS1 Antibody, clone 243

MABF2185-100UG
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information
      Description
      Catalogue NumberMABF2185-100UG
      DescriptionAnti-Dengue Virus 2 NS1 Antibody, clone 243
      Alternate Names
      • DENV NS1 protein
      Background InformationDengue virus (DENV) is a mosquito-borne flavivirus and is one of the most common mosquito-transmitted viral infections. The DENV particle is about 500 nm in diameter and includes a positive-sense RNA genome with ~10,700 nucleotides and 3 structural proteins known as capsid (C), precursor membrane (prM), and envelope (E) proteins. In addition, the RNA genome of dengue virus also encodes seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) that are shown to be essential for viral replication. DENV NS1, a 48-kDa glycoprotein (aa 776-1127 of genome polyprotein), is highly conserved among all flaviviruses and is essential for viral replication. It is expressed as a monomer in infected cells and after post-translational modification in the lumen of endoplasmic reticulum, it forms homodimers associated with organelle membranes and the cell membrane. NS1 is reported to be involved in immune evasion, pathogenesis, and viral replication. Once cleaved off the polyprotein, is targeted to three destinations: the viral replication cycle, the plasma membrane and the extracellular compartment. NS1 is secreted in a hexamer form, which is composed of three dimers with a detergent-sensitive hydrophobic central cavity and it plays a role against host immune response. NS1 is shown to induce expression of sialidases, heparanase, and activates cathepsin L, which activates heparinase via enzymatic cleavage. These effects are may contribute to the endothelial hyperpermeability commonly observed in severe dengue disease. During the recovery phase, NS1 is cleared from the circulation by antibody-mediated effects. (Ref.: Chen, RU et al. (2018). J. Biomed. Sci. 25(1); 58; Bosch, I., et al. (2017). Sci. Transl. Med. 9(409); eaan1589).
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Applications
      ApplicationAnti-Dengue Virus 2 NS1, clone 243, Cat. No. MABF2185, is mouse monoclonal antibody that detects Dengue virus 2 NS1 protein and has been tested for use in ELISA and Flow Cytometry.
      Key Applications
      • ELISA
      • Flow Cytometry
      Application NotesELISA Analysis: A representative lot of this antibody detected Dengue Virus 2 NS1 in ELISA applications (Bosch, I., et. al. (2017). Sci. Transl. Med. 9(409); eaan1589).

      Flow Cytometry Analysis: A representative lot of this antibody detected Dengue Virus 2 NS1 in Flow Cytometry applications (Bosch, I., et. al. (2017). Sci. Transl. Med. 9(409); eaan1589).
      Biological Information
      ImmunogenPurified recombinant Dengue virus 2 NS1 protein expressed in mammalian cells.
      Clone243
      ConcentrationPlease refer to lot specific datasheet.
      HostMouse
      SpecificityClone 243 is a mouse monoclonal antibody that specifically detects Dengue virus 2 NS1 protein. It targets an epitope within 18 amino acids from the beta-ladder region.
      IsotypeIgG1κ
      Species Reactivity
      • Virus
      Species Reactivity NoteVirus (Dengue virus).
      Antibody TypeMonoclonal Antibody
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight~48 kDa calculated for NS1 protein; 378.71 kDa for the entire genome polyprotein.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by ELISA with DENV2 NS1 recombinant protein.

      ELISA Analysis: 5 µg/mL of this antibody detected Dengue Virus 2 NS1 recombinant protein.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalog Number GTIN
      MABF2185-100UG 04061841190431

      Documentation

      Anti-Dengue Virus 2 NS1 Antibody, clone 243 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Dengue Virus 2 NS1 Antibody, clone 243 Certificates of Analysis

      TitleLot Number
      Anti-Dengue Virus 2 NS1, clone 243 - Q3327023 Q3327023

      References

      Reference overviewPub Med ID
      Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.
      Bosch, I; de Puig, H; Hiley, M; Carré-Camps, M; Perdomo-Celis, F; Narváez, CF; Salgado, DM; Senthoor, D; O'Grady, M; Phillips, E; Durbin, A; Fandos, D; Miyazaki, H; Yen, CW; Gélvez-Ramírez, M; Warke, RV; Ribeiro, LS; Teixeira, MM; Almeida, RP; Muñóz-Medina, JE; Ludert, JE; Nogueira, ML; Colombo, TE; Terzian, ACB; Bozza, PT; Calheiros, AS; Vieira, YR; Barbosa-Lima, G; Vizzoni, A; Cerbino-Neto, J; Bozza, FA; Souza, TML; Trugilho, MRO; de Filippis, AMB; de Sequeira, PC; Marques, ETA; Magalhaes, T; Díaz, FJ; Restrepo, BN; Marín, K; Mattar, S; Olson, D; Asturias, EJ; Lucera, M; Singla, M; Medigeshi, GR; de Bosch, N; Tam, J; Gómez-Márquez, J; Clavet, C; Villar, L; Hamad-Schifferli, K; Gehrke, L
      Sci Transl Med  9  N/A  2017

      Show Abstract
      28954927 28954927